National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 12849 [2024-03381]
Download as PDF
12849
Federal Register / Vol. 89, No. 34 / Tuesday, February 20, 2024 / Notices
Responses
per
respondent
Number of
respondents
Hours per
response
Total
burden
hours
Administrative Hearings reporting requirements ................
0
0.0
0
0.000
0
HPSL Subtotal .............................................................
NSL:
Student Financial Aid Transcript ........................................
Entrance Interview ..............................................................
Exit Interview ......................................................................
Notification of Repayment ..................................................
Notification During Deferment ............................................
Notification of Delinquent Accounts ....................................
Credit Bureau Notification ...................................................
Write-off of Uncollectable Loans ........................................
Disability Cancellation .........................................................
Administrative Hearings ......................................................
........................
........................
........................
........................
310,670
4,100
282
348
348
348
348
348
23
16
0
1.0
17.5
9.0
9.0
1.5
42.5
709.0
1.0
1.0
0.0
4,100
4,935
3,132
3,132
522
14,790
246,732
23
16
0
0.250
0.420
0.420
0.270
0.290
0.040
0.006
3.000
1.000
0.000
1,025
2,073
1,315
846
151
592
1,480
69
16
0
NSL Subtotal ...............................................................
........................
........................
........................
........................
7,567
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–03331 Filed 2–16–24; 8:45 am]
BILLING CODE 4165–15–P
Dated: February 14, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
Total
annual
responses
[FR Doc. 2024–03385 Filed 2–16–24; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
BILLING CODE 4140–01–P
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence Study
Section.
Date: March 14–15, 2024.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Kazuyo Kegan, AB, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–S,
Bethesda, MD 20892, (301) 435–0270,
kazuyo.kegan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
VerDate Sep<11>2014
16:54 Feb 16, 2024
Jkt 262001
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Diagnostic Centers of
Excellence for the Undiagnosed Diseases
Network.
Date: March 28–29, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Nilkantha Sen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/HHS, NSC, 6001 Executive
Blvd., Rockville, MD 20852, 301–496–9223
nilkantha.sen@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; HEAL: Small molecule and
biologics to treat pain.
Date: March 29, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: W. Ernest Lyons, Ph.D.,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS 6001
Executive Blvd., Rockville, MD 20852, 301–
496–4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: February 14, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–03381 Filed 2–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
E:\FR\FM\20FEN1.SGM
20FEN1
Agencies
[Federal Register Volume 89, Number 34 (Tuesday, February 20, 2024)]
[Notices]
[Page 12849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03381]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Diagnostic Centers of Excellence
for the Undiagnosed Diseases Network.
Date: March 28-29, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852.
Contact Person: Nilkantha Sen, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH/HHS, NSC, 6001 Executive Blvd., Rockville, MD 20852, 301-496-
9223 [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; HEAL: Small molecule and
biologics to treat pain.
Date: March 29, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852.
Contact Person: W. Ernest Lyons, Ph.D., Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS 6001 Executive Blvd., Rockville, MD
20852, 301-496-4056, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
Dated: February 14, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03381 Filed 2-16-24; 8:45 am]
BILLING CODE 4140-01-P